4,550.00

Content Details
Information on this page was last modified on : 2021/05/11 4:29:31 PM

ENCAVIR 0.05mg Suspension 210ml

Entecavir:0.05mg | Antiretroviral drugs

Manufactured / Marketed By : Selmore Product Form : SuspensionPack Size : 210mlIngredients : Entecavir:0.05mgGeneric Category : Antiretroviral drugs

How it works

ENCAVIR 0.05mg Suspension 210ml works by decreasing the amount of hepatitis B virus (HBV) in the body.

Side effects

Major & minor side effects for ENCAVIR 0.05mg Suspension 210ml

  • Allergy severe
  • Diarrhoea
  • Elevated Liver Enzymes
  • Insomnia
  • Fatigue
  • Headache
  • Dizziness

Uses of ENCAVIR 0.05mg Suspension 210ml

What is it prescribed for?

  • Chronic Hepatitis B

    This medicine is used in the treatment of chronic hepatitis B infection, if no nucleoside reverse transcriptase inhibitors (NRTIs) like lamivudine were previously used or if resistance is developed to the existing NRTI therapy.

Concerns

Frequently asked questions

  • Onset of action

    The time at which this medicine shows its effect is not clinically established.

  • Duration of Effect

    There is no well-established clinical data available regarding the duration of action of this medicine.

  • Safe with Alchohol?

    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

  • Is it habit forming?

    No habit forming tendencies were reported.

  • Usage in pregnancy?

    This medicine is not recommended for use in pregnant women unless strictly indicated. The benefits and risks should be discussed with the doctor before using this medicine.

  • Usage while breast-feeding?

    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. Your doctor may advise you to discontinue breastfeeding or to discontinue the medicine based on your clinical condition.

When not to use?

  • Allergy

    This medicine is not recommended for use in patients with a known allergy to ENCAVIR 0.05mg Suspension 210ml .

Warnings

Warnings for special population
  • Pregnancy

    This medicine is not recommended for use in pregnant women unless strictly indicated. The benefits and risks should be discussed with the doctor before using this medicine.

  • Breast-feeding

    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. Your doctor may advise you to discontinue breastfeeding or to discontinue the medicine based on your clinical condition.

General Warnings
  • Exacerbation of Hepatitis B

    Discontinuation of ENCAVIR 0.05mg Suspension 210ml or any other anti-Hepatitis B therapy may cause severe acute exacerbation of the HBV infection. Monitoring of liver function is recommended for at least a few months after stopping the treatment with this medicine. Further initiation of anti-Hepatitis B therapy may be warranted in a few cases.

  • HIV co-infection

    This medicine is not recommended for use in patients who are infected with human immunodeficiency virus (HIV) and not on highly active antiretroviral therapy (HAART) therapy for HIV due to the risk of development of resistance to HIV NRTIs.

  • Lactic Acidosis

    This medicine is not recommended for use in patients with severe liver dysfunction due to the risk of lactic acidosis (increased acid in the blood). Frequent clinical monitoring for lactic acidosis is recommended while taking this medicine. Any symptoms like difficulty in breathing, irregular heartbeats, dark-coloured urine, and yellow colored skin and eyes should be reported to the doctor on priority.

Dosage

  • Missed Dose

    If a dose of ENCAVIR 0.05mg Suspension 210ml is missed, take the dose as soon as you remember. If it is almost the time for the next dose, skip the missed dose and take the next dose. Do not double the dose to make up for the missed one.

  • Overdose

    Seek emergency medical treatment or contact the doctor in case of an overdose.

Interactions

Interaction with Medicines
  • Metformin moderate
  • Aminoglycoside antibiotics moderate
  • NSAIDs moderate
Disease interactions
  • moderate

    This medicine should be used with extreme caution in patients with renal dysfunction. Renal function should be assessed before initiating the treatment with this medicine. Appropriate dosage adjustment should be made based on the renal function.

Food interactions
  • The desired effect of ENCAVIR 0.05mg Suspension 210ml will not be achieved if it is taken with food. Hence, it is advisable to take this medicine on an empty stomach unless otherwise specified by the doctor. It is recommended that you take this medicine 2 hours before or after meals.

General Instructions

Do not use This medicine for any conditions other than those specified by the doctor. Do not share the medicine with anyone else. Report to the doctor all your medical conditions and current medicines before taking this medication. Report any undesired effects or lack of improvement to the doctor on priority.

Other details

  • To be taken on an empty stomach
  • To be taken as instructed by doctor
  • Does not cause sleepiness

References

Additional Information:

One of the following licensed pharmacy from the nearest location will deliver ENCAVIR 0.05mg Suspension 210ml. The details of the licensed pharmacy shall be shared once you request the drugs and the respective pharmacy accepts your request based on valid prescription and availability.

Want to share this information?
Facebook
Twitter
LinkedIn
Something doesn't feel right ?

Questions and Answers

There are no questions yet. Be the first to ask a question about this product.

Only registered users are eligible to enter questions

Reviews

There are no reviews yet.

Be the first to review “ENCAVIR 0.05mg Suspension 210ml”
Shopping Cart